Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. (Record no. 17055184)

MARC details
000 -LEADER
fixed length control field 01476 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515070441.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200708s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1007-9327
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3748/wjg.v13.i16.2328
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Peyrin-Biroulet, Laurent
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070820
245 00 - TITLE STATEMENT
Title Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. World journal of gastroenterology
Date of publication, distribution, etc. Apr 2007
300 ## - PHYSICAL DESCRIPTION
Extent 2328-32 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adalimumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Inflammatory Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element C-Reactive Protein
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colitis, Ulcerative
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Tolerance
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infliximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Subcutaneous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Remission Induction
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Laclotte, Cécile
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roblin, Xavier
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bigard, Marc-André
773 0# - HOST ITEM ENTRY
Title World journal of gastroenterology
Related parts vol. 13
-- no. 16
-- p. 2328-32
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3748/wjg.v13.i16.2328">https://doi.org/10.3748/wjg.v13.i16.2328</a>
Public note Available from publisher's website

No items available.